We are looking for children 2–17 years old to join a CD medical research study to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or moderately to severely active IBD (including associated symptoms such as stomach pain, loss of appetite, diarrhea, malnutrition and/or eye pain), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrolling for a limited time.
